# Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

> **NCT00899262** · — · UNKNOWN · sponsor: **South West Wales Cancer Institute** · enrollment: 300 (estimated)

## Conditions studied

- Lung Cancer
- Tobacco Use Disorder

## Interventions

- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **OTHER:** sputum cytology
- **PROCEDURE:** Fourier transform infrared spectroscopy
- **PROCEDURE:** diagnostic bronchoscopy

## Key facts

- **NCT ID:** NCT00899262
- **Lead sponsor:** South West Wales Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899262, "Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00899262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*